Sisram Medical Gestione
Gestione criteri di controllo 2/4
Sisram Medical Il CEO è Lior Dayan, nominato in Jun2017, e ha un mandato di 7.42 anni. la retribuzione annua totale è $ 1.53M, composta da 56.6% di stipendio e 43.4% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.2% delle azioni della società, per un valore di HK$ 3.34M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 1.8 anni e 7.3 anni.
Informazioni chiave
Lior Dayan
Amministratore delegato
US$1.5m
Compenso totale
| Percentuale dello stipendio del CEO | 56.6% |
| Mandato del CEO | 7.4yrs |
| Proprietà del CEO | 0.2% |
| Durata media del management | 1.8yrs |
| Durata media del Consiglio di amministrazione | 7.3yrs |
Aggiornamenti recenti sulla gestione
Recent updates
What Sisram Medical Ltd's (HKG:1696) 40% Share Price Gain Is Not Telling You
Oct 07
Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?
Aug 23Not Many Are Piling Into Sisram Medical Ltd (HKG:1696) Just Yet
Jul 24Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)
Jun 17Returns On Capital At Sisram Medical (HKG:1696) Have Stalled
Apr 21Does Sisram Medical (HKG:1696) Have A Healthy Balance Sheet?
Mar 28Estimating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)
Mar 05Take Care Before Diving Into The Deep End On Sisram Medical Ltd (HKG:1696)
Jan 23Is Sisram Medical Ltd (HKG:1696) Potentially Undervalued?
Dec 29Is Sisram Medical (HKG:1696) Using Too Much Debt?
Nov 09Returns On Capital At Sisram Medical (HKG:1696) Have Stalled
Oct 19At HK$6.71, Is It Time To Put Sisram Medical Ltd (HKG:1696) On Your Watch List?
Sep 18Sisram Medical (HKG:1696) Is Paying Out A Larger Dividend Than Last Year
Aug 14Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?
Jun 16Sisram Medical (HKG:1696) Shareholders Will Want The ROCE Trajectory To Continue
May 30Is Sisram Medical (HKG:1696) Using Too Much Debt?
Apr 19Is Now The Time To Look At Buying Sisram Medical Ltd (HKG:1696)?
Mar 01Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital
Jan 12Sisram Medical (HKG:1696) Has A Rock Solid Balance Sheet
Dec 21Should You Investigate Sisram Medical Ltd (HKG:1696) At HK$7.99?
Dec 01Some Investors May Be Worried About Sisram Medical's (HKG:1696) Returns On Capital
Oct 14Here's Why We Think Sisram Medical (HKG:1696) Is Well Worth Watching
Sep 28These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely
Aug 25Should You Think About Buying Sisram Medical Ltd (HKG:1696) Now?
Aug 01These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely
May 19Is Sisram Medical Ltd (HKG:1696) Trading At A 29% Discount?
May 03If You Like EPS Growth Then Check Out Sisram Medical (HKG:1696) Before It's Too Late
Apr 11Sisram Medical (HKG:1696) Is Experiencing Growth In Returns On Capital
Mar 17Is Now An Opportune Moment To Examine Sisram Medical Ltd (HKG:1696)?
Nov 22Calculating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)
Aug 22Be Wary Of Sisram Medical (HKG:1696) And Its Returns On Capital
Jul 27Here's Why We Think Sisram Medical Ltd's (HKG:1696) CEO Compensation Looks Fair
Jun 24Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$24m |
| Mar 31 2024 | n/a | n/a | US$28m |
| Dec 31 2023 | US$2m | US$863k | US$31m |
| Sep 30 2023 | n/a | n/a | US$35m |
| Jun 30 2023 | n/a | n/a | US$38m |
| Mar 31 2023 | n/a | n/a | US$39m |
| Dec 31 2022 | US$3m | US$1m | US$40m |
| Sep 30 2022 | n/a | n/a | US$38m |
| Jun 30 2022 | n/a | n/a | US$35m |
| Mar 31 2022 | n/a | n/a | US$33m |
| Dec 31 2021 | US$2m | US$767k | US$31m |
| Sep 30 2021 | n/a | n/a | US$28m |
| Jun 30 2021 | n/a | n/a | US$24m |
| Mar 31 2021 | n/a | n/a | US$19m |
| Dec 31 2020 | US$769k | US$596k | US$13m |
| Sep 30 2020 | n/a | n/a | US$13m |
| Jun 30 2020 | n/a | n/a | US$13m |
| Mar 31 2020 | n/a | n/a | US$17m |
| Dec 31 2019 | US$759k | US$606k | US$21m |
| Sep 30 2019 | n/a | n/a | US$22m |
| Jun 30 2019 | n/a | n/a | US$24m |
| Mar 31 2019 | n/a | n/a | US$23m |
| Dec 31 2018 | US$884k | US$560k | US$22m |
| Sep 30 2018 | n/a | n/a | US$18m |
| Jun 30 2018 | n/a | n/a | US$14m |
| Mar 31 2018 | n/a | n/a | US$12m |
| Dec 31 2017 | US$829k | US$361k | US$11m |
Compensazione vs Mercato: La retribuzione totale di Lior ($USD 1.53M ) è superiore alla media delle aziende di dimensioni simili nel mercato Hong Kong ($USD 359.96K ).
Compensazione vs guadagni: La retribuzione di Lior è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Lior Dayan (54 yo)
7.4yrs
Mandato
US$1,526,000
Compensazione
Mr. Lior Moshe Dayan has been Chief Executive Officer and Executive Director at Sisram Medical Ltd since June 6, 2017 and its President since 2023 and is responsible for its overall and day-to-day manageme...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Executive Chairman | 8.6yrs | US$27.00k | 0.053% HK$ 890.0k | |
| President | 7.4yrs | US$1.53m | 0.20% HK$ 3.3m | |
| Chief Financial Officer | less than a year | Nessun dato | Nessun dato | |
| Chief Operating Officer | 6.6yrs | Nessun dato | Nessun dato | |
| VP of Finance | 1.8yrs | Nessun dato | Nessun dato | |
| Chief Information Officer | less than a year | Nessun dato | Nessun dato | |
| Chief Marketing Officer | 1.8yrs | Nessun dato | Nessun dato | |
| Chief People Officer | 1.8yrs | Nessun dato | Nessun dato | |
| President of ROW | 1.8yrs | Nessun dato | Nessun dato | |
| EVP of R&D | 1.8yrs | Nessun dato | Nessun dato | |
| President NA | 1.8yrs | Nessun dato | Nessun dato | |
| Company Secretary | 2.8yrs | Nessun dato | Nessun dato |
1.8yrs
Durata media
51.5yo
Età media
Gestione esperta: Il team dirigenziale di 1696 non è considerato esperto (durata media 1.8 anni), il che suggerisce un nuovo team.
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Executive Chairman | 8.6yrs | US$27.00k | 0.053% HK$ 890.0k | |
| President | 7.4yrs | US$1.53m | 0.20% HK$ 3.3m | |
| Independent Non-Executive Director | 7.3yrs | US$32.00k | Nessun dato | |
| Non-Executive Director | 8.1yrs | Nessun dato | Nessun dato | |
| Independent Non-Executive Director | 7.3yrs | US$32.00k | Nessun dato | |
| Independent Non-Executive Director | 7.3yrs | US$32.00k | Nessun dato | |
| Independent Non-Executive Director | 7.3yrs | US$32.00k | Nessun dato | |
| Non-Executive Director | 4.3yrs | Nessun dato | Nessun dato |
7.3yrs
Durata media
51.5yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 1696 sono considerati esperti (durata media dell'incarico 7.3 anni).